Annual Cash & Cash Equivalents
$351.19 M
-$200.62 M-36.36%
31 December 2023
Summary:
Apellis Pharmaceuticals annual cash & cash equivalents is currently $351.19 million, with the most recent change of -$200.62 million (-36.36%) on 31 December 2023. During the last 3 years, it has fallen by -$214.59 million (-37.93%). APLS annual cash & cash equivalents is now -45.14% below its all-time high of $640.19 million, reached on 31 December 2021.APLS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$396.86 M
+$36.78 M+10.21%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly cash and cash equivalents is currently $396.86 million, with the most recent change of +$36.78 million (+10.21%) on 30 September 2024. Over the past year, it has dropped by -$55.55 million (-12.28%). APLS quarterly cash and cash equivalents is now -48.13% below its all-time high of $765.08 million, reached on 31 March 2023.APLS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.4% | -12.3% |
| 3 y3 years | -37.9% | +39.9% |
| 5 y5 years | +99.2% | -8.6% |
APLS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.1% | at low | -48.1% | +39.9% |
| 5 y | 5 years | -45.1% | +99.2% | -48.1% | +49.5% |
| alltime | all time | -45.1% | +7280.3% | -48.1% | +3855.9% |
Apellis Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $396.86 M(+10.2%) |
| June 2024 | - | $360.09 M(+10.5%) |
| Mar 2024 | - | $325.92 M(-7.2%) |
| Dec 2023 | $351.19 M(-36.4%) | $351.19 M(-22.4%) |
| Sept 2023 | - | $452.41 M(-26.6%) |
| June 2023 | - | $616.26 M(-19.5%) |
| Mar 2023 | - | $765.08 M(+38.7%) |
| Dec 2022 | $551.80 M(-13.8%) | $551.80 M(-5.5%) |
| Sept 2022 | - | $584.19 M(-3.4%) |
| June 2022 | - | $604.49 M(-4.6%) |
| Mar 2022 | - | $633.46 M(-1.1%) |
| Dec 2021 | $640.19 M(+13.2%) | $640.19 M(+125.6%) |
| Sept 2021 | - | $283.75 M(+4.8%) |
| June 2021 | - | $270.76 M(+2.0%) |
| Mar 2021 | - | $265.44 M(-53.1%) |
| Dec 2020 | $565.78 M | $565.78 M(+36.1%) |
| Sept 2020 | - | $415.56 M(+30.9%) |
| June 2020 | - | $317.35 M(-24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $417.88 M(+18.7%) |
| Dec 2019 | $351.99 M(+99.7%) | $351.99 M(-18.9%) |
| Sept 2019 | - | $433.99 M(+50.1%) |
| June 2019 | - | $289.13 M(+0.3%) |
| Mar 2019 | - | $288.25 M(+63.5%) |
| Dec 2018 | $176.27 M(+0.4%) | $176.27 M(-20.1%) |
| Sept 2018 | - | $220.64 M(-13.1%) |
| June 2018 | - | $253.84 M(+66.0%) |
| Mar 2018 | - | $152.93 M(-12.9%) |
| Dec 2017 | $175.64 M(+606.4%) | $175.64 M(+1237.1%) |
| Sept 2017 | - | $13.14 M(-74.8%) |
| June 2017 | - | $52.19 M(+109.9%) |
| Dec 2016 | $24.86 M(-30.9%) | $24.86 M(-30.9%) |
| Dec 2015 | $36.00 M(+164.3%) | $36.00 M(+258.9%) |
| Sept 2015 | - | $10.03 M(-32.5%) |
| June 2015 | - | $14.87 M(+9.1%) |
| Dec 2014 | $13.62 M(+186.3%) | $13.62 M |
| Dec 2013 | $4.76 M | - |
FAQ
- What is Apellis Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Apellis Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Apellis Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of APLS is $351.19 M
What is the all time high annual cash & cash equivalents for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual cash & cash equivalents is $640.19 M
What is Apellis Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, APLS annual cash & cash equivalents has changed by -$200.62 M (-36.36%)
What is Apellis Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APLS is $396.86 M
What is the all time high quarterly cash and cash equivalents for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly cash and cash equivalents is $765.08 M
What is Apellis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, APLS quarterly cash and cash equivalents has changed by -$55.55 M (-12.28%)